N

NeoVac

15 employees

NeoVac is creating a revolutionary, unique and proprietary next generation lipid nanoparticles to enable RNA vaccines for various diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2021

Funding rounds raised

N

NeoVac raised undisclosed on November 1, 2021

Investors: Future Planet Capital

FAQ